152 related articles for article (PubMed ID: 38726203)
1. Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells:
Shahbazi S; Tafvizi F; Naseh V
Heliyon; 2024 May; 10(9):e30503. PubMed ID: 38726203
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
3. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction.
Liao C; Xu D; Liu X; Fang Y; Yi J; Li X; Guo B
Int J Nanomedicine; 2018; 13():4417-4431. PubMed ID: 30104875
[TBL] [Abstract][Full Text] [Related]
4. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Protamine Letrozole Nanoparticles: A Promising Strategy to Combat Human Breast Cancer via MCF-7 Cell Lines.
Khan MT; Uddin Z; Javed MA; Shah N; Bashir H; Shaikh AJ; Rajoka MSR; Amirzada MI; Asad MHHB
Biomed Res Int; 2022; 2022():4438518. PubMed ID: 35722457
[TBL] [Abstract][Full Text] [Related]
6. Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells.
Shin JH; Shin DH; Kim JS
Asian J Pharm Sci; 2020 Jul; 15(4):472-481. PubMed ID: 32952670
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
8. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
[TBL] [Abstract][Full Text] [Related]
9. Preparation of UiO-66 loaded Letrozole nano-drug delivery system: enhanced anticancer and apoptosis activity.
Ronaghi M; Hajibeygi R; Ghodsi R; Eidi A; Bakhtiari R
AMB Express; 2024 Apr; 14(1):38. PubMed ID: 38622436
[TBL] [Abstract][Full Text] [Related]
10. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells.
Fahmy SA; Ramzy A; Mandour AA; Nasr S; Abdelnaser A; Bakowsky U; Azzazy HME
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214139
[TBL] [Abstract][Full Text] [Related]
11. Development of optimized novel liposome loaded with 6-gingerol and assessment of its therapeutic activity against NSCLC In vitro and In vivo experimental models.
Thangavelu P; Sundaram V; Gunasekaran K; Mujyambere B; Raju S; Kannan A; Arasu A; Krishna K; Ramamoorthi J; Ramasamy S; Velusamy T; Samiappan S
Chem Phys Lipids; 2022 Jul; 245():105206. PubMed ID: 35483420
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
[TBL] [Abstract][Full Text] [Related]
13. Novel Metal-Organic Framework Nanoparticle for Letrozole Delivery: A New Advancement in Breast Cancer Treatment.
Hashemi A; Rezaei N; Shirkavand F; Gholizadeh F; Baghbani-Arani F
J Pharm Sci; 2024 Mar; ():. PubMed ID: 38492847
[TBL] [Abstract][Full Text] [Related]
14. An ATF
Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X
Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399
[No Abstract] [Full Text] [Related]
15. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
16. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of letrozole-loaded spray dried liposomes with PEs for topical application.
Maniyar M; Chakraborty A; Kokare C
J Liposome Res; 2020 Sep; 30(3):274-284. PubMed ID: 31223043
[TBL] [Abstract][Full Text] [Related]
18. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
19. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
20. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
